A simple Self-Test could transform cervical cancer screening access
NCT ID NCT05390567
First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time
Summary
This trial tests whether giving women the choice to use an HPV self-test at home, instead of only offering in-clinic Pap tests, improves their adherence to cervical cancer screening. It involves 800 women aged 25-65 who have not had cervical cancer or a hysterectomy. Participants may choose between a self-test kit or a standard Pap test, and the study tracks whether they complete screening and follow-up steps. The goal is to see if offering self-testing helps overcome barriers like transportation and increases screening rates among underserved populations.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- HPV self-test kit and standard in-clinic Pap test
- What this could lead to
- If offering HPV self-tests improves screening adherence, it could help reduce cervical cancer rates among underserved women who face barriers to clinic visits.
- What could go wrong
- The trial is still in progress, and results may not show a significant improvement. Some women may not return the self-test or may still miss follow-up care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER SCREENING METHODS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Florida
RECRUITINGGainesville, Florida, 32610, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.